DrugPatentWatch Database Preview
Novast Labs Company Profile
What is the competitive landscape for NOVAST LABS, and what generic and branded alternatives to NOVAST LABS drugs are available?
NOVAST LABS has forty-nine approved drugs.
There are three tentative approvals on NOVAST LABS drugs.
Summary for Novast Labs
| US Patents: | 0 |
| Tradenames: | 47 |
| Ingredients: | 33 |
| NDAs: | 49 |
Drugs and US Patents for Novast Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novast Labs | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209674-001 | Nov 2, 2018 | AB2 | RX | No | No | Start Trial | Start Trial | ||||
| Novast Labs | SETLAKIN | ethinyl estradiol; levonorgestrel | TABLET;ORAL | 090716-001 | Sep 15, 2014 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Novast Labs | LARIN 24 FE | ethinyl estradiol; norethindrone acetate | TABLET;ORAL | 202994-001 | Feb 18, 2015 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
